Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Research Capital

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison Jul 16, 2023 9:38pm

233 Views

Post# 35543501

RE:RE:RE:RE:RE:Research Capital

Legit62 wrote: My feeling is Research Capital is not going to push our SP higher, the data and BTD along with JV deal will get us higher, but still nice to get someone writing about us, counting the days

Agree 100 percent Legit62

<< Previous

Bullboard Posts

Next >>

AI companies to invest in